Cargando…
SAT-LB83 Amiodarone Induced Myxedema Coma
Introduction Amiodarone is widely used as a rhythm-conversion agent in atrial fibrillation. It’s low negative inotropic activity and low risk of ventricular arrhythmia makes it an advantageous agent for atrial arrhythmia. One of the major limiting factors in the use of amiodarone can be its thyroid...
Autores principales: | Kim, Keun Young, Syed, Sabah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208672/ http://dx.doi.org/10.1210/jendso/bvaa046.2241 |
Ejemplares similares
-
SAT-624 Amiodarone-Induced Myxedema Coma
por: Rana, Sanah, et al.
Publicado: (2019) -
SAT-619 Myxedema Coma: A Modern Day Rarity
por: Ramachandran, Aishwarya, et al.
Publicado: (2019) -
FRI502 Myxedema Coma With An Unusual Pattern Of Thyroid Function Tests Due To Amiodarone-induced Hypothyroidism
por: Nguyen, Son, et al.
Publicado: (2023) -
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020) -
SAT-499 Myxedema Coma Presenting as Large Pericardial Effusion with Cardiac Tamponade
por: Ramos, Freyja Diana A, et al.
Publicado: (2020)